BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2812968
Number of visits today
370
Number of downloads
2063811
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Singh A, Neupane YR, Mangla B, Shafi S, Kohli K. PEGylated Nanoliposomes Potentiated Oral Combination Therapy for Effective Cancer Treatment. CDD 2020;17:728-35. [DOI: 10.2174/1567201817666200724170708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tyagi N, Gupta P, Khan Z, Neupane YR, Mangla B, Mehra N, Ralli T, Alhalmi A, Ali A, Al Kamaly O, Saleh A, Nasr FA, Kohli K. Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer. Molecules 2023;28. [PMID: 36903587 DOI: 10.3390/molecules28052343] [Reference Citation Analysis]
2 Frézard F, Aguiar MMG, Ferreira LAM, Ramos GS, Santos TT, Borges GSM, Vallejos VMR, De Morais HLO. Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics 2022;15. [PMID: 36678729 DOI: 10.3390/pharmaceutics15010099] [Reference Citation Analysis]
3 Kenguva G, Bandaru R, Rout SR, Greish K, Kesharwani P, Dandela R. Combination drug delivery approaches for cancer therapy. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 2022. [DOI: 10.1016/b978-0-323-85873-1.00010-1] [Reference Citation Analysis]
4 Song X, Luo Y, Ma L, Hu X, Simal-gandara J, Wang L, Bajpai VK, Xiao J, Chen F. Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent. Seminars in Cancer Biology 2021;73:331-46. [DOI: 10.1016/j.semcancer.2021.03.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345